L01BA04
E561030
L01BA04 is the ATC classification code for pemetrexed, a chemotherapy agent used primarily in the treatment of malignant pleural mesothelioma and non-small cell lung cancer.
Statements (25)
| Predicate | Object |
|---|---|
| instanceOf |
ATC code
ⓘ
pharmacologic classification code ⓘ |
| ATCLevel1 | L ⓘ |
| ATCLevel1Description | Antineoplastic and immunomodulating agents ⓘ |
| ATCLevel2 | L01 ⓘ |
| ATCLevel2Description | Antineoplastic agents ⓘ |
| ATCLevel3 | L01B ⓘ |
| ATCLevel3Description | Antimetabolites ⓘ |
| ATCLevel4 | L01BA ⓘ |
| ATCLevel4Description | Folic acid analogues ⓘ |
| belongsToGroup | antifolate antimetabolites ⓘ |
| chemicalSubstance | pemetrexed ⓘ |
| codingSystem | Anatomical Therapeutic Chemical classification system NERFINISHED ⓘ |
| countryScope | international ⓘ |
| hasDefinedDailyDose | yes ⓘ |
| hasRouteOfAdministration | intravenous use ⓘ |
| indication |
malignant pleural mesothelioma
ⓘ
non-small cell lung cancer ⓘ |
| maintainedBy | WHO Collaborating Centre for Drug Statistics Methodology NERFINISHED ⓘ |
| molecularTargetClass | folate-dependent enzymes ⓘ |
| refersTo | pemetrexed NERFINISHED ⓘ |
| regulatoryContext | WHO ATC/DDD system NERFINISHED ⓘ |
| targetsDiseaseType | malignant neoplasms ⓘ |
| therapeuticArea | oncology ⓘ |
| usedAs | chemotherapy agent ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.